Recursive partitioning analysis for the prediction of stereotactic radiosurgery brain metastases lesion control

Oncologist

Volumn 18, Issue 3, 2013, Pages 330-335

  Rodrigues, George ^a,b   Zindler, Jaap ^c   Warner, Andrew ^a   Lagerwaard, Frank ^c  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Brain metastases; Local control; Predictive modeling; Recursive partitioning analysis; Stereotactic radiosurgery

Indexed keywords

GADOLINIUM;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN METASTASIS; CANCER CONTROL; CANCER GROWTH; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; RADIATION DOSE; RECURSIVE PARTITIONING ANALYSIS; RETROSPECTIVE STUDY; STEREOTACTIC RADIOSURGERY; TREATMENT OUTCOME; TUMOR VOLUME;

EID: 84875422311     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2012-0316     Document Type: Article

References (22)

1. Tsao MN, Lloyd N, Wong RK, et al. Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases. Cochrane Database Syst Rev 2012;4:CD003869.
2. Tsao MN, Lloyd NS, Wong RK et al. Radiotherapeutic management of brain metastases: A systematic review and meta-analysis. Cancer Treat Rev 2005;31:256-273.
3. Nieder C, Mehta MP. Prognostic indices for brain metastases: Usefulness and challenges. Radiat Oncol 2009;4:10.
4. Tsao MN, Rades D, Wirth A, et al. Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guideline. Pract Radiat Oncol 2012;2:210-225.
5. Andrews DW, Scott CB, Sperduto PW et al. Whole brain radiation therapy with or without stereotactic radiosurgeryboostforpatientswithonetothreebrain metastases: Phase III results of the RTOG 9508 randomised trial. Lancet 2004;363:1665-1672.
6. Kocher M, Soffietti R, Abacioglu U et al. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: Results of the EORTC 22952-26001 study. J Clin Oncol 2011;29:134-141.
7. Aoyama H, Shirato H, Tago M et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs. stereotactic radiosurgery alone for treatment of brain metastases: A randomized controlled trial. JAMA 2006;295:2483-2491.
8. Aoyama H, Tago M, Kato N et al. Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys 2007;68:1388-1395.
9. Chang EL, Wefel JS, Hess KR, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: A randomised controlled trial. Lancet Oncol 2009;10:1037-1044.
10. Linskey ME, Andrews DW, Asher AL et al. Therole of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: A systematic review and evidence-based clinical practice guideline. J Neurooncol 2010;96:45-68.
11. Breneman JC, Warnick RE, Albright RE Jr. et al. Stereotactic radiosurgery for the treatment of brain metastases. Results of a single institution series. Cancer 1997;79:551-557.
12. Molenaar R, Wiggenraad R, Verbeek-de Kanter A et al. Relationship between volume, dose and local control in stereotactic radiosurgery of brain metastasis. Br J Neurosurg 2009;23:170-178.
13. Regine WF, Huhn JL, Patchell RA et al. Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagnosed brain metastases: Results and implications. Int J Radiat Oncol Biol Phys 2002; 52:333-338.
14. Schomas DA, Roeske JC, MacDonald RL et al. Predictors of tumor control in patients treated with LINAC-based stereotactic radiosurgery for metastatic disease to the brain. Am J Clin Oncol 2005;28: 180-187.
15. Shehata MK, Young B, Reid B, et al. Stereotatic radiosurgery of 468 brain metastases≤ 2 cm: Implications for SRS dose and whole brain radiation therapy. Int J Radiat Oncol Biol Phys 2004; 59:87-93.
16. Wiggenraad R, Verbeek-de Kanter A, Kal HB et al. Dose-effect relation in stereotactic radiotherapy for brain metastases. A systematic review. Radiother Oncol 2011;98:292-297.
17. Shiau CY, Sneed PK, Shu HK et al. Radiosurgery for brain metastases: Relationship of dose and pattern of enhancement to local control. Int J Radiat Oncol Biol Phys 1997;37:375-383.
18. Goodman KA, Sneed PK, McDermott MW et al. Relationship between pattern of enhancement and local control of brain metastases after radiosurgery. Int J Radiat Oncol Biol Phys 2001; 50:139-146.
19. Schemper M, Smith TL. A note on quantifying follow-up in studies of failure time. Control Clin Trials 1996;17:343-346.
20. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Amer Statist Assn 1958;53:457-481.
21. Cook EF, Goldman L. Empiric comparison of multivariate analytic techniques: Advantages and disadvantages of recursive partitioning analysis. J Chronic Dis 1984;37:721-731.
22. Rades D, Dunst J, Schild SE et al. A new scoring system to predict the survival of patients treated with whole-brain radiotherapy for brain metastases. Strahlenther Onkol. 2008;184:251-255.